European Journal of Gynaecological Oncology (EJGO)

European Journal of Gynaecological Oncology

Print ISSN: 0392-2936 | Online ISSN: 2709-0086

European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.

Articles

Microbiota, a new tool for gynaecological cancer prevention and treatment

Franco Borruto,Christophe Robino,Ciro Comparetto

DOI: 10.22514/ejgo.2025.075

Abstract ( 519 ) PDF (349.45 kB) ( 146 ) Full Text

Open Access

Developments in ovarian cancer markers and algorithms

Minting Xu,Rong Liang,Anqi Zhang,Zhenzhen Wang,Lili Zhang

DOI: 10.22514/ejgo.2025.076

Abstract ( 474 ) PDF (348.37 kB) ( 116 ) Full Text

Open Access

Prognostic factors and corresponding nursing measures for patients with endometrial cancer: a systematic review and meta-analysis

Yuhong Xu,Xueling Qi,Tianwei Gao,Jianying Wang,Lili Chai

DOI: 10.22514/ejgo.2025.077

Abstract ( 425 ) PDF (3.1 MB) ( 141 ) Full Text

Open Access

The prognostic role of miR-181a-5p in advanced stages epithelial ovarian cancer patients enrolled in MITO16A/MaNGO-OV2 clinical trial

Lara Paracchini,Gian Franco Zannoni,Laura Arenare,Anna Spina,Loris De Cecco,Giovanni Scambia,Daniela Gallo,Carmela Pisano,Daniela Califano,Annamaria Ferrero,Giosuè Scognamiglio,Sabrina Chiara Cecere,Daniela Russo,Clorinda Schettino,Delia Mezzanzanica,Enrico Breda,Paolo Chiodini,Elena Biagioli,Francesco Perrone,Maurizio D’Incalci,Sandro Pignata,Sergio Marchini

DOI: 10.22514/ejgo.2025.078

Abstract ( 448 ) PDF (6.5 MB) ( 136 ) Full Text

Open Access

Fused in sarcoma (FUS) expression may predict survival outcomes of patients with advanced squamous cell cervical carcinoma

Ana Maria Dias Fachini,Luís Otávio Sarian,Maria Cecília Ramiro Talarico,Rafaella Almeida Lima Nunes,Larissa Bastos Eloy da Costa,Antonio Carlos Zuliani,Enrique Boccardo,Lara Termini,Silvia Helena Rabelo-Santos,Luiz Carlos Zeferino

DOI: 10.22514/ejgo.2025.079

Abstract ( 424 ) PDF (2.01 MB) ( 142 ) Full Text

Open Access

Effect of a fermented dairy beverage on radiation-related gastrointestinal toxicity and inflammation in locally advanced cervical cancer patients, a randomized placebo-controlled pilot study

Denisse Castro-Eguiluz,Julissa Luvián-Morales,Merari Delgadillo González,Clementina Castro Hernández,Aurora Espejel Núñez,Alejandra Rueda Escalona,Christian Aguila Mancera,María Guadalupe Serna Thomé,Lucely del Carmen Cetina-Pérez

DOI: 10.22514/ejgo.2025.080

Abstract ( 477 ) PDF (6.03 MB) ( 127 ) Full Text

Open Access

Comprehensive analysis of the impact of circulating metabolites on the risk of endometrial cancer: a Mendelian randomization study

Hua Yang

DOI: 10.22514/ejgo.2025.081

Abstract ( 422 ) PDF (3.43 MB) ( 145 ) Full Text

Open Access

Prognostic analysis of splenic parenchymal metastasis in patients with advanced ovarian cancer

Jeeyeon Kim,Junghoe Kim,Jimin Lee,Joo-Hyuk Son,Tae-Wook Kong,Suk-Joon Chang

DOI: 10.22514/ejgo.2025.082

Abstract ( 454 ) PDF (3.45 MB) ( 127 ) Full Text

Open Access

Ultrasound features of non-circumscribed margin associates with favorable prognosis in breast cancer patients in China: a retrospective cohort study

Nan Jiang,Guofen Zhang,Haiyan Ma,Yun L,Dan Li,Lijie Pan,Yumeng Liu,Lihong Liu,Hongjuan Han,Xiangli Li,Xin Wang

DOI: 10.22514/ejgo.2025.083

Abstract ( 444 ) PDF (10.09 MB) ( 149 ) Full Text

Open Access

Study on the relationship between serum miR-146a-5p and miR-151a-3p and the sensitivity of synchronized radiotherapy in patients with locally advanced cervical cancer

Wei Chen,Wei Zhang,Xiaoyu Ji,Yingnan Jin

DOI: 10.22514/ejgo.2025.084

Abstract ( 428 ) PDF (579.77 kB) ( 107 ) Full Text

Open Access

Diagnostic and prognostic significance of internal tRNA-derived fragment glycine-glycine-cytosine (itRNAGlyGCC) expression in epithelial ovarian cancer

Amal F. Gharib,Haytham Dahlawi,Ahmed Alghamdi,Amani A. Alrehaili,Maha M. Bakhuraysah,Rehab Ahmed Karam,Tamer Mohamed Abdelrhman,Wael H. Elsawy

DOI: 10.22514/ejgo.2025.085

Abstract ( 444 ) PDF (1.89 MB) ( 146 ) Full Text

Open Access

KRT15 promotes proliferation, migration and invasion of cervical cancer cells

Mo Li,Chenchen Tian,Limei Zhang

DOI: 10.22514/ejgo.2025.086

Abstract ( 416 ) PDF (2.35 MB) ( 129 ) Full Text

Open Access

Survival outcomes of HER2 low patients with metastatic breast cancer: a retrospective analysis

Ozlem Dogan,Hayriye Sahinli,Ebru Cilbir,Yakup Duzkopru

DOI: 10.22514/ejgo.2025.087

Abstract ( 421 ) PDF (4.22 MB) ( 135 ) Full Text

Open Access

Analysis of the clinical value of O-RADS classification combined with hematological indexes in the diagnosis of benign and malignant tumors of ovary-adnexa

Lewei Zhan,Li Zhang,Chunlai Zhang

DOI: 10.22514/ejgo.2025.088

Abstract ( 441 ) PDF (1.42 MB) ( 149 ) Full Text

Open Access

Ovarian apocrine carcinoma arising from a mature cystic teratoma: a case report

Hirofumi Kawahara,Riho Yumisashi,Yuuka Fukunishi,Mitsuharu Nomoto,Masaki Kamio

DOI: 10.22514/ejgo.2025.089

Abstract ( 423 ) PDF (9 MB) ( 132 ) Full Text

all

Published Ahead of Print

Open Access

Expression and clinical significance of CSAD in type I endometrial carcinoma

Hao Huang,Mengni Wang,Xiaojing Chen,Qin Chen,Yan Feng,Baohua Li

Online publish date: 28 October 2024

DOI: 10.22514/ejgo.2024.110

Abstract ( 1848 ) PDF (21.78 MB) ( 182 ) Full Text

all

Special Issues

Special issue title:

Quality of Life in Gynecologic Malignancies

Keywords: Quality of life; Palliative care; Symptom management

Editor: Lori Spoozak, MD

Submission deadline: 31 December 2024

Special issue title:

Endometrial Cancer and Fertility Preservation in the Denatality ERA

Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve

Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.

Submission deadline: 31 December 2025

Special issue title:

Advances in Ovarian Cancer Research

Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation

Editor: Basel Refky, MD

Submission deadline: 31 July 2025

Special issue title:

Current Update in the Treatment of Cervical Cancer

Keywords: Radical Hysterectomy; Fertility Sparing; Oncological Outcomes

Editor: Carlo Ronsini, MD

Submission deadline: 31 December 2025

Special issue title:

Gynecological Cancer Prevention: A New Prospective

Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology

Editor: Ottavia Dʼoria, MD

Submission deadline: 31 October 2023

Special issue title:

Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods

Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer

Editor: Prof. Takuma Hayashi

Submission deadline: 31 October 2023

Special issue title:

Molecular Characterization in Endometrial Cancer: Progress and Prospects

Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine

Editor: Andrea Giannini, MD, PhD

Submission deadline: 31 December 2022

Special issue title:

Immunotherapy for Gynecological Oncology

Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer

Editor: Tadahiro Shoji, MD

Submission deadline: 31 July 2021

Special issue title:

Enhanced Recovery of Gynecological Oncology

Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management

Editor: Lin Li, MD

Submission deadline: 31 December 2022

Special issue title:

Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy

Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers

Editor: Sharad Ghamande, MD,David Mysona, MD

Submission deadline: 30 March 2022

all

Featured Article

Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181

To Be a Reviewer

If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.

Review for EJGO

Join Editorial Board

You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.

Join Editorial Board

Editor-in-Chief

Prof. Enrique Hernandez, MD, FACOG, FACS.

Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.

Current Issue

Vol., Issue , Invalid date

Table of contents
All Issues

Submit to EJGO Review for EJGO Edit a Special Issue

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Impact Factor 2024: 0.5